 |
Related Articles |
Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review.
Am J Addict. 2017 Mar;26(2):99-111
Authors: Adisetiyo V, Gray KM
Abstract
BACKGROUND/OBJECTIVES: Children with attention-deficit/hyperactivity disorder (ADHD) are nearly three times more likely to develop substance use disorders (SUD) than their typically developing peers. Our objective was to review the existing neuroimaging research on high-risk ADHD (ie, ADHD with disruptive behavior disorders, familial SUD and/or early substance use), focusing on impulsivity as one possible mechanism underlying SUD risk.
METHODS: A PubMed literature search was conducted using combinations of the keywords “ADHD,” “substance use,” “substance use disorder,” “SUD,” “addiction,” “dependence,” “abuse,” “risk,” “brain” “MRI,” “imaging” and “neuroimaging.” Studies had to include cohorts that met diagnostic criteria for ADHD; studies of individuals with ADHD who all met criteria for SUD were excluded. Eight studies met the search criteria.
RESULTS: Individuals with high-risk ADHD have hyperactivation in the motivation-reward processing brain network during tasks of impulsive choice, emotion processing, and risky decision-making. During response inhibition tasks, they have hypoactivation in the inhibitory control brain network. However, studies focusing on this latter circuit found hypoactivation during inhibitory control tasks, decreased white matter microstructure coherence and reduced cortical thickness in ADHD independent of substance use history.
DISCUSSION/CONCLUSIONS: An exaggerated imbalance between the inhibitory control network and the motivation-reward processing network is theorized to distinguish individuals with high-risk ADHD. Preliminary findings suggest that an exaggerated aberrant reward processing network may be the driving neural correlate of increased SUD risk in ADHD.
SCIENTIFIC SIGNIFICANCE: Neural biomarkers of increased SUD risk in ADHD could help clinicians identify which patients may benefit most from SUD prevention. Thus, more neuroimaging research on this vulnerable population is needed. (Am J Addict 2017;26:99-111).
PMID: 28106934 [PubMed – indexed for MEDLINE]
via https://www.ncbi.nlm.nih.gov/pubmed/28106934?dopt=Abstract